Schizencephaly

Schizencephaly is a rare and serious neuropsychiatric developmental disorder characterized by irregular cavities in the cerebral hemispheres resulting from disruption of the normal process of neurogenesis. The disorder can manifest itself in varying degrees of severity and can cause a wide range of neurological disorders. Schizencephaly is usually associated with clinical manifestations such as mental retardation, epilepsy, movement disorders, and behavioral abnormalities, which significantly affects the quality of life of patients. The occurrence of this condition is usually associated with abnormalities in the development of the cerebral cortex and can be related to both genetic and environmental factors.

History of the disease and interesting historical facts

Schizencephaly was first described in medical literature at the beginning of the 20th century, but some references to such a pathology can be found in earlier works devoted to various anomalies of brain development. One of the first cases of a detailed description of schizencephaly was presented in 1940, when researchers began to aggregate the clinical manifestations of the disorder and distinguish the disease from other congenital anomalies. Historically, such pathologies were often interpreted as an expression of general mental retardation, and only in recent decades has medicine begun to recognize the diversity of clinical manifestations and discover the mechanisms of the formation of this pathology. Interestingly, at different times, schizencephaly was considered not only from a medical point of view, but also in a social context, when people with such anomalies were often stigmatized and subjected to non-social adaptation.

Epidemiology

Current research suggests that the incidence of schizencephaly varies by region and demographics. Estimates range from 1 to 5 cases per 10,000 live births. Schizencephaly can be diagnosed in various age groups, but most cases are detected in young children during neonatal screening. Sample size and diagnostic methods can significantly affect these rates, so local conditions and available neonatal screening resources must be considered.

Genetic predisposition to this disease

Schizencephaly has a strong genetic predisposition, as confirmed by the results of genetic studies revealing an association with a number of mutations in specific genes. The genes involved include:

• GPR56
• COL4A1
• RELI_UTRF
• EMX2

Mutations in these genes can lead to abnormalities in the structure and function of neurons, which in turn causes abnormal formation of the cerebral cortex and the development of schizencephaly. Importantly, inheritance can be either dominant or recessive, which necessitates genetic counseling for high-risk families.

Risk factors for the development of this disease

Risk factors that contribute to the development of schizencephaly are divided into physical and chemical:

• Infections during pregnancy (eg, CMV, STDs)
• Maternal alcohol and drug use
• Use of drugs that are potentially harmful to the fetus (eg, valproic acid)
• Genome abnormalities (chromosomal abnormalities)
• Environmental factors (high levels of environmental pollution)

Identification and control of such factors are important primary prevention measures that can reduce the risk of developing this disease in newborns.

Diagnosis of this disease

Diagnosis of schizencephaly is a multi-step process that includes clinical examination, laboratory and radiological studies:

• Main symptoms: developmental delay, seizures, physical abnormalities (eg, microcephaly).
• Laboratory tests: genetic testing for specific mutations.
• Radiological examinations: Magnetic resonance imaging (MRI) can visualize structural abnormalities in the brain.
• Other types of diagnostics: neuropsychological tests to assess cognitive functions.
• Differential diagnosis: It is important to exclude other conditions such as lissencephaly and articulated brain.

Treatment

Treatment of schizencephaly is complex and multifaceted. There are several approaches:

• General treatment: creation of individual rehabilitation programs aimed at developing motor and cognitive functions.
• Pharmacological treatment: prescription of antiepileptic drugs to control seizures, as well as the use of nootropic agents to improve cognitive functions.
• Surgical treatment: In some cases, neurosurgical correction may be considered, taking into account the depth of structural changes.
• Other types of treatment: use of physical therapy, speech therapy and psychotherapy to develop communication skills and adapt to life.

The effectiveness of treatment varies and depends on the severity of pathological changes.

List of medications used to treat this disease

The following medications may be prescribed for the treatment of schizencephaly:

• Lamotrigine
• Carbamazepine
• Valproic acid
• Topiramate
• Clonazepam

These drugs can be used to control epileptic attacks and other associated symptoms.

Disease monitoring

Monitoring of patients with schizencephaly includes regular examinations to assess neurological status, mental development, and general health. It is recommended to perform:

• Control stages: regular clinical examinations with a psychologist and neurologist.
• Prognosis: depends on the severity of the disease and associated disorders.
• Complications: May include progression to mental retardation, development of status epilepticus, problems with coordination and learning.

Age-related features of the disease

Schizencephaly has its own age-related characteristics:

• In newborns: often detected only during routine examination.
• In a child: May manifest as difficulties in development and social skills.
• In adulthood: cognitive decline and social problems may occur.

The process of monitoring the development of a child with schizencephaly requires an individual approach and comprehensive planning.

Questions and Answers

• What are the main symptoms of schizencephaly? The main symptoms are developmental delay, seizures and various physical abnormalities.
• Can schizencephaly be prevented? Prevention involves eliminating risk factors such as infections during pregnancy and giving up bad habits.
• How is schizencephaly diagnosed? Diagnosis includes clinical examination, genetic tests, and imaging studies such as MRI.
• What is the prognosis for patients with schizencephaly? The prognosis depends on the severity of the disease; in most cases, specialized rehabilitation is required.
• What treatment is used for patients with schizencephaly? Treatment includes drug therapy, rehabilitation and sometimes surgery.